Mydecine Innovations Group (NEOE:MYCO) Days Payable : 0.00 (As of Sep. 2023)

View and export this data going back to 2014. Start your Free Trial

What is Mydecine Innovations Group Days Payable?

Mydecine Innovations Group's average Accounts Payable for the three months ended in Sep. 2023 was C$3.32 Mil. Mydecine Innovations Group's Cost of Goods Sold for the three months ended in Sep. 2023 was C$0.00 Mil.

The historical rank and industry rank for Mydecine Innovations Group's Days Payable or its related term are showing as below:

During the past 10 years, Mydecine Innovations Group's highest Days Payable was 205.73. The lowest was 205.73. And the median was 205.73.

NEOE:MYCO's Days Payable is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 86.23
* Ranked among companies with meaningful Days Payable only.

Mydecine Innovations Group's Days Payable stayed the same from Sep. 2022 (0.00) to Sep. 2023 (0.00). stayed the same

Mydecine Innovations Group Days Payable Historical Data

The historical data trend for Mydecine Innovations Group's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mydecine Innovations Group Days Payable Chart

Mydecine Innovations Group Annual Data

Trend

Dec13

Aug14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Days Payable

Get a 7-Day Free Trial

205.73

Mydecine Innovations Group Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Days Payable	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Mydecine Innovations Group's Days Payable

For the Drug Manufacturers - Specialty & Generic subindustry, Mydecine Innovations Group's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Mydecine Innovations Group's Days Payable Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Mydecine Innovations Group's Days Payable distribution charts can be found below:

* The bar in red indicates where Mydecine Innovations Group's Days Payable falls into.

Mydecine Innovations Group Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Mydecine Innovations Group's Days Payable for the fiscal year that ended in Dec. 2022 is calculated as

	Days Payable (A: Dec. 2022 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2021 )	+	Accounts Payable (A: Dec. 2022 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2022 )	*	Days in Period
=	( (0.451	+	3.809)	/	2 )	/	0	*	365
=	2.13					/	0	*	365
=	N/A

Mydecine Innovations Group's Days Payable for the quarter that ended in Sep. 2023 is calculated as:

	Days Payable (Q: Sep. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Jun. 2023 )	+	Accounts Payable (Q: Sep. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Sep. 2023 )	*	Days in Period
=	( (3.425	+	3.214)	/	2 )	/	0	*	365 / 4
=	3.3195					/	0	*	365 / 4
=	N/A

Mydecine Innovations Group Days Payable Related Terms

Thank you for viewing the detailed overview of Mydecine Innovations Group's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Mydecine Innovations Group (NEOE:MYCO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mydecine Innovations Group Inc (NEOE:MYCO) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

MYCOF:USA 0NF0:Germany MYCO:Canada

Address

789 West Pender Street, Suite 810, Vancouver, BC, CAN, V6C 1H2

Website

https://www.mydecine.com

Mydecine Innovations Group Inc is a biopharma and life sciences company engaged in the research, drug development, and clinical trials of psilocybin products.

Mydecine Innovations Group (NEOE:MYCO) Headlines

No Headlines